卵巢癌的神经上皮质起源是通过表皮-介质细胞-外皮过渡来解释的,这种过渡得到了cisplatin的加强
David Díaz-Carballo1, Ayesha Safoor2, Sahitya Saka3
1Institute of Molecular Oncology and Experimental Therapeutics, Division of Hematology and Oncology, Ruhr University Bochum Medical School, Marien Hospital Herne, Düngelstr. 33, 44623, Herne, Germany. david.diaz-carballo@marienhospital-herne.de.
Scientific reports
|November 26, 2024
概括
卵巢癌细胞在接受西斯治疗时经历了一种新的上皮-介质-外皮过渡 (EMET),发展神经特征和多药性耐药性 (MDR). 这表明卵巢癌的神经皮质干细胞起源.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 发展生物学 发展生物学
背景情况:
- 对衍生物化疗的获得性耐药性是治疗卵巢癌的一个重要障碍.
- 了解细胞可塑性和卵巢癌的起源对于开发有效疗法至关重要.
研究的目的:
- 为了研究卵巢癌对西斯普拉丁治疗的细胞反应.
- 确定驱动卵巢癌进化和耐药性的细胞的起源和特征.
主要方法:
- 在用西斯普拉丁治疗的卵巢癌细胞中分析表皮-介质细胞过渡 (EMT) 标记物和神经元标记物.
- 卵巢癌细胞与神经/干细胞和多药耐药性 (MDR) 现型的分离和特征.
- 培养卵巢癌细胞作为有机体,观察形态变化.
- 在正常卵巢组织中识别和表征类似细胞群.
主要成果:
- 西斯普拉丁治疗在卵巢癌细胞中诱导了上皮-介质-外皮过渡 (EMET),其特征是上皮标记物的下调,维丁的上调以及胚胎和神经元标记物的表达.
- 分离了具有双神经/干细胞特征和MDR表型的细胞,并观察到上皮细胞与这些群体有差异.
- 神经元形态迅速诱导在卵巢癌细胞培养为有机体.
- 在正常的卵巢组织中发现了一种具有神经/干细胞特征的独特细胞类型,并且在卵巢瘤中被发现被放大,这表明它具有神经上皮原点.
结论:
- 卵巢癌很可能起源于具有内在神经/干细胞特征和MDR特征的小细胞亚群.
- 已确定的EMET过程和神经皮质干细胞群是卵巢癌发展和治疗耐药性的关键因素.
相关概念视频
Oogenesis
63.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancers Originate from Somatic Mutations in a Single Cell
11.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.6K


